About: http://data.cimple.eu/news-article/3289224bd7caa72eb007be053721355d61a3e091e46572e5e6aabc49

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/3289224bd7caa72eb007be053721355d61a3e091e46572e5e6aabc49 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	Patients with high blood pressure admitted to hospital with coronavirus infections are twice as likely to die as those without the condition, researchers said on Friday. For in-patients with the virus who had stopped taking medication for high blood pressure, the risk of dying doubled again, they reported in the European Heart Journal. "It is important that patients with high blood pressure realise that they are at increased risk of dying from COVID-19," said senior author Fei Li, a cardiologist at Xijing Hospital in Xian, China. For the study, researchers in China and Ireland retroactively examined cases admitted to Huoshenshan Hospital in Wuhan between February 5 and March 15. Nearly 30 percent -- 850 patients -- had a history of hypertension, another term for high blood pressure. Four percent of those patients died, compared with just over one percent of the 2,027 patients without hypertension. After adjusting for age, sex and other medical conditions, the researchers calculated that having high blood pressure increased the risk of dying two-fold. In a separate meta-analysis of three other studies covering 2,300 COVID-19 patients from the same hospital, the researchers investigated the impact of different blood pressure drugs on death rates. Contrary to their expectations, they found that a class of drugs known as RAAS inhibitors -- which include angiotensin-converting enzyme inhibitors (ACE) and angiotensin receptor blockers (ARB) -- were not linked to higher COVID-19 mortality. Indeed, the risk appeared to be somewhat diminished. "We suggest that patients should not discontinue or change their usual anti-hypertensive treatment unless instructed by a physician," said co-author Ling Tao, a professor at Xijing Hospital. The authors noted that their study was observational and not based on clinical trials, meaning further research was needed before they could make firm clinical recommendations. prk-mh/jxb
schema:headline	Virus patients with high blood pressure twice as likely to die: study
schema:mentions	Angiotensin Cell surface receptor Angiotensin-converting enzyme ACE inhibitor Meta-analysis Huoshenshan Hospital Cardiology Hypertension Blood pressure Physician Republic of Ireland Lithium Mortality rate Wuhan Virus China Coronavirus Severe acute respiratory syndrome coronavirus 2 South Caribbean Coast Autonomous Region European Heart Journal
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2020-06-04 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	negative sentiment
http://data.cimple...readability_score	82 (xsd:integer)
http://data.cimple...tology#hasEmotion	fear

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 5 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software